BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20236727)

  • 21. [Clinical research on surgical treatment for non-small cell lung cancer of diameter less than 2 cm].
    Wei L; Zhao S; Chen MY; Chen Z; Chen X
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2502-4. PubMed ID: 24300276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is lobe specific lymph node dissection adequate for cN0-1 non-small cell lung cancer?
    Fang L; Xu J; Ye B; Yu G; Chen G; Yang J
    J Cardiothorac Surg; 2020 Feb; 15(1):46. PubMed ID: 32106870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.
    Guo D; Ni Y; Lv X; Zhang Z; Ye P
    J Cancer Res Ther; 2016 Oct; 12(Supplement):120-125. PubMed ID: 27721268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of nodal spread patterns according to tumor location in pathological N2 non-small cell lung cancer.
    Shimada Y; Saji H; Kakihana M; Honda H; Usuda J; Kajiwara N; Ohira T; Ikeda N
    World J Surg; 2012 Dec; 36(12):2865-71. PubMed ID: 22948194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer.
    Takizawa T; Terashima M; Koike T; Akamatsu H; Kurita Y; Yokoyama A
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):248-52. PubMed ID: 9040617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis.
    Fukui T; Katayama T; Ito S; Abe T; Hatooka S; Mitsudomi T
    Lung Cancer; 2009 Dec; 66(3):309-13. PubMed ID: 19344976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
    Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
    Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transbronchial needle aspiration cytology of subcarinal lymph nodes for the staging procedure in the diagnosis of lung cancer.
    Aono H; Okamoto H; Kunikane H; Nagatomo A; Watanabe K; Nagai A
    Respirology; 2006 Nov; 11(6):782-5. PubMed ID: 17052308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How extensive should lymph node dissection be done for the surgery of the left lung cancer?].
    Hirono T; Yamato Y; Souma T; Yoshiya K; Nakayama K; Tsuchida M; Aoki T; Watanabe T; Eguchi S
    Kyobu Geka; 1994 Jan; 47(1):20-3. PubMed ID: 8277626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Exploration of lymph node metastasis and appropriate lymph node dissection modes in patients with clinical stage I non-small cell lung cancer].
    Zhang Z; Mao Y; He J; Gao S; Cheng G; Liu X; Fang D; Li J; Wang Y; Wang D; Mu J; Xue Q; Gao Y; Zhao J; Zhang L; Huang J; Wang B; Ding N
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):536-40. PubMed ID: 25327661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence and distribution of mediastinal lymph node metastasis and its impact on survival in patients with non-small-cell lung cancers 3 cm or less: data from 2292 cases.
    Yang MZ; Hou X; Liang RB; Lai RC; Yang J; Li S; Long H; Fu JH; Lin P; Wang X; Rong TH; Yang HX
    Eur J Cardiothorac Surg; 2019 Jul; 56(1):159-166. PubMed ID: 30668665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Incidence of lymph node involvement in pN2 non-small cell lung carcinoma and reevaluation of the lymph node dissection method].
    Shiba M; Yamaguchi Y; Takeda T
    Kyobu Geka; 1994 Jan; 47(1):33-6. PubMed ID: 8277629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy.
    Sakao Y; Miyamoto H; Yamazaki A; Ou S; Shiomi K; Sonobe S; Sakuraba M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):543-7. PubMed ID: 16870462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis.
    Watanabe S; Suzuki K; Asamura H
    Ann Thorac Surg; 2008 Mar; 85(3):1026-31. PubMed ID: 18291191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
    Wu XW; Chen T; Yin S; Deng Y; Zhao B
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.